| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$79,134 ) |
| | 2027 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | CPIMP221350 | ROLE: Reducing Risk for Readmission, Optimizing Language Access and Improving Equity | 03 | 3 | DHHS/OS | 10/6/2026 | -$79,134 |
| | 2027 | 2023 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | CPIMP221350 | ROLE: Reducing Risk for Readmission, Optimizing Language Access and Improving Equity | 03 | 3 | DHHS/OS | 10/6/2026 | $0 |
| | 2027 | 2022 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | CPIMP221350 | ROLE: Reducing Risk for Readmission, Optimizing Language Access and Improving Equity | 03 | 3 | DHHS/OS | 10/6/2026 | $0 |
|
| Issue Date FY: 2026 ( Subtotal = $75,053,702 ) (Continued on the next page) |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | H79TI087343 | Project TINES (Trauma-Informed Nursing Education on Substance Use) | 007 | 3 | SAMHSA | 7/14/2026 | $299,274 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R00NS128258 | Structural and Functional Studies on Proton-activated Chloride (PAC) Channel | 000 | 5 | NIH | 8/7/2026 | $248,999 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 5 | NIH | 1/22/2026 | $390,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 000 | 3 | NIH | 4/27/2026 | $555,192 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI195642 | Regulation of cytoskeletal reorganization by Chlamydia | 000 | 1 | NIH | 9/2/2026 | $558,367 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | H79SM092614 | Establishing a Trauma-Informed Suicide Prevention Community Treatment and Service Center in Philadelphia | 001 | 1 | SAMHSA | 9/21/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | H79SM092614 | Establishing a Trauma-Informed Suicide Prevention Community Treatment and Service Center in Philadelphia | 000 | 1 | SAMHSA | 9/17/2026 | $598,231 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21HG014909 | Sensitive and Accurate Quantification Of Small RNAs At Single-nucleotide Resolution From Deep Sequencing Data | 000 | 1 | NIH | 9/14/2026 | $431,750 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R56NS118082 | Molecular mechanisms of triplet repeat instability in Huntington's disease | 000 | 6 | NIH | 9/17/2026 | $539,089 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD122769 | Tailored strategies to improve recommended postpartum care and maternal health outcomes | 000 | 1 | NIH | 9/17/2026 | $849,505 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI200840 | DNA-PK inhibition to abolish HIV gene products | 000 | 1 | NIH | 9/9/2026 | $803,550 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | U2F55884 | The Sickle Cell Disease Regional Quality Care Program (SoRCE-Q) | 00 | 1 | HRSA | 9/14/2026 | $950,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM167167 | Understanding the regulation and function of autophagy of mitochondria containing mtDNA | 000 | 1 | NIH | 8/17/2026 | $392,500 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA318624 | CONNECT: Combining Navigation, Networks, and Electronic monitoring to improve endoCrine Therapy adherence | 000 | 1 | NIH | 8/12/2026 | $651,545 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | P01CA298993 | Neuroendocrine Prostate Cancer Progression and Novel Therapeutic Vulnerabilities | 000 | 1 | NIH | 4/27/2026 | $1,656,379 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | P01HL180318 | Exploiting emerging ideas in G protein-coupled receptor biology and pharmacology to treat asthma | 000 | 2 | NIH | 9/11/2026 | $2,325,263 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI195907 | A Single Shot Measles Vectored Rabies Vaccine for Children | 000 | 1 | NIH | 6/30/2026 | $641,084 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA303372 | Microbubble augmentation of immunotherapy in head and neck cancer | 001 | 1 | NIH | 7/15/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA308347 | Contrast-enhanced Ultrasound Evaluation of Indeterminate Ovarian Lesions: Prospective Multicenter Study | 000 | 1 | NIH | 6/30/2026 | $671,674 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA303372 | Microbubble augmentation of immunotherapy in head and neck cancer | 000 | 1 | NIH | 6/8/2026 | $401,115 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21MH138289 | DNA-PK impact on HIV reservoir in the CNS | 000 | 1 | NIH | 5/18/2026 | $431,750 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30CA306004 | Investigating immunomodulation of p53 mutant ovarian cancer | 001 | 1 | NIH | 8/6/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30CA306004 | Investigating immunomodulation of p53 mutant ovarian cancer | 000 | 1 | NIH | 8/6/2026 | $51,477 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI190368 | Trained Immunity Induced by mRNA-LNP | 000 | 1 | NIH | 2/19/2026 | $813,921 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA308034 | The role of NSD2-NEO1 axis in CNS infiltration of acute lymphoblastic leukemia | 000 | 1 | NIH | 8/18/2026 | $492,980 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DA064690 | Leveraging Longitudinal Data to Examine ADHD Stimulant Treatment Patterns and Substance Use Outcomes in Adolescents | 000 | 1 | NIH | 8/21/2026 | $279,294 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30AI197381 | Ion Channels as Targets for an anti- Tick Vaccine | 001 | 1 | NIH | 8/6/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30AI197381 | Ion Channels as Targets for an anti- Tick Vaccine | 000 | 1 | NIH | 8/6/2026 | $51,477 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21HD118201 | Group based well child care for mothers with history of hypertensive disorder during pregnancy | 000 | 1 | NIH | 8/19/2026 | $438,910 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL179441 | Role of isoAsp-induced protein damage in diabetic angiogenesis | 000 | 1 | NIH | 7/7/2026 | $629,068 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI196695 | Molecular factors governing the biogenesis and release of short immunostimulatory RNAs | 000 | 1 | NIH | 7/6/2026 | $235,500 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R34CA297502 | Assessing the Feasibility of a Remotely-Delivered Tai Chi Intervention for Older GI Cancer Patients Experiencing Chemotherapy-Induced Peripheral Neuropathy | 000 | 1 | NIH | 6/30/2026 | $312,363 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI196199 | Role of the solute carrier 15A4 in anti-microbial inflammatory responses and autophagy in dendritic cells | 000 | 1 | NIH | 8/11/2026 | $712,776 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03AI202317 | Mitochondrial solute carriers on phagosomes in dendritic cells | 000 | 1 | NIH | 7/7/2026 | $78,500 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA301616 | Spatial heterogeneity of Her2 expression in luminal breast cancer | 000 | 1 | NIH | 5/1/2026 | $646,208 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AG101730 | Epigenetically Preserved iNSCs to Study dsRNA-Mediated Inflammation in C9orf72-ALS/FTD | 000 | 1 | NIH | 8/27/2026 | $429,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DA065026 | Xylazine, Pregnancy, and Access to Care | 000 | 1 | NIH | 2/12/2026 | $346,500 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DA065026 | Xylazine, Pregnancy, and Access to Care | 002 | 1 | NIH | 9/16/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DA065026 | Xylazine, Pregnancy, and Access to Care | 001 | 1 | NIH | 4/7/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI194176 | Avian influenza virus prevention in the domestic host by a deactivated vaccine | 000 | 1 | NIH | 6/19/2026 | $221,250 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS146192 | Role of the Metabolic Homeostasis-ISR Axis in C9orf72-ALS/FTD | 000 | 1 | NIH | 8/26/2026 | $653,174 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F31CA309862 | Bi-functional degrader with treatment potential for B-cell lymphoma | 001 | 1 | NIH | 5/13/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F31CA309862 | Bi-functional degrader with treatment potential for B-cell lymphoma | 000 | 1 | NIH | 5/13/2026 | $50,114 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AA031540 | Skeletal Innervation in Fetal Alcohol Syndrome | 000 | 1 | NIH | 7/27/2026 | $419,080 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA317293 | Enhancing sensitivity to GNAQ/11 pathway inhibitors by antagonizing the serotonin HTR2B receptor in uveal melanoma | 000 | 1 | NIH | 7/27/2026 | $403,686 |
|
